US Patent Issued to Accutar Biotechnology on June 17 for "Compounds having BET, estrogen receptor, androgen receptor degradation activity and uses thereof" (New York, Indiana Inventors)

ALEXANDRIA, Va., June 19 -- United States Patent no. 12,331,061, issued on June 17, was assigned to Accutar Biotechnology Inc. (Brooklyn, N.Y.).

"Compounds having BET, estrogen receptor, androgen receptor degradation activity and uses thereof" was invented by Jie Fan (Brooklyn, N.Y.), Wei He (Brooklyn, N.Y.) and Ke Liu (Brooklyn, Ind.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Compounds, pharmaceutical compositions containing such compounds, and their use in prevention and treatment of cancer and other related diseases and conditions are disclosed. In an embodiment, the disclosed compounds have the following Formula (I) and pharmaceutically acceptable salts thereof:"

The patent was filed on April 17, 20...